Acriptega FC tablets
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in adults and children weighing at least 40 kg.
Dosage (summary)
One tablet taken orally once daily, with or without food.
Onset of Action / Duration
Viral load reduction may be observed within 2 to 4 weeks; full therapeutic effect may take several months.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
- Patients with a history of psychiatric disorders
Pregnancy & Breastfeeding
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Not recommended during breastfeeding due to potential transmission of HIV.
Key Drug Interactions
- Caution with other antiretroviral agents
- Potential interactions with drugs that affect renal function
- Caution with drugs that induce or inhibit CYP450 enzymes
Contraindications
- Hypersensitivity to any component of the formulation
- Severe renal impairment (eGFR < 30 mL/min)
- Severe hepatic impairment
Common side effects
- Nausea
- Diarrhea
- Fatigue
- Headache
- Insomnia
- Rash
- Elevated liver enzymes
Counselling Points
- Adherence to the prescribed regimen is crucial for treatment success.
- Inform patients about the importance of regular follow-up and monitoring.
- Advise patients to report any signs of allergic reactions or severe side effects.
- Discuss the potential for drug interactions and the importance of informing healthcare providers about all medications being taken.
Serious warnings
- Risk of lactic acidosis and severe hepatomegaly with steatosis.
- Monitor for signs of immune reconstitution syndrome.
- Caution in patients with a history of depression or other mental health disorders.
Important Disclaimer
The Acriptega FC tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
